Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition.

Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, Morris JC, Raichle ME, Mintun MA.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17763-7. doi: 10.1073/pnas.1010461107.

2.

Brain aerobic glycolysis functions and Alzheimer's disease.

Vlassenko AG, Raichle ME.

Clin Transl Imaging. 2015 Feb 1;3(1):27-37.

3.

Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions?

Phelps ME, Barrio JR.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17459-60. doi: 10.1073/pnas.1012684107. No abstract available.

4.

Regional aerobic glycolysis in the human brain.

Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17757-62. doi: 10.1073/pnas.1010459107.

5.

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.

Jagust WJ, Landau SM; Alzheimer's Disease Neuroimaging Initiative..

J Neurosci. 2012 Dec 12;32(50):18227-33. doi: 10.1523/JNEUROSCI.3266-12.2012.

6.

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.

Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC.

Neuroimage Clin. 2014 Feb 19;4:604-14. doi: 10.1016/j.nicl.2014.02.001.

7.

Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.

Lim HK, Nebes R, Snitz B, Cohen A, Mathis C, Price J, Weissfeld L, Klunk W, Aizenstein HJ.

Brain. 2014 Dec;137(Pt 12):3327-38. doi: 10.1093/brain/awu271.

8.

Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Oh H, Madison C, Baker S, Rabinovici G, Jagust W.

Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108.

PMID:
27190008
9.

ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?

Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D Jr.

Med Hypotheses. 2012 Apr;78(4):494-6. doi: 10.1016/j.mehy.2012.01.015.

PMID:
22285195
10.

Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloid.

Yamada M, Tsukagoshi H, Otomo E, Hayakawa M.

Acta Neuropathol. 1988;77(2):136-41.

PMID:
3067504
11.

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, Debnath ML, Holt DP, Huang GF, Shao L, DeKosky ST, Price JC, Mathis CA.

J Neurosci. 2005 Nov 16;25(46):10598-606.

12.

[Default mode network and Alzheimer's disease].

Vergara E F, Behrens MI.

Rev Med Chil. 2013 Mar;141(3):375-80. doi: 10.4067/S0034-98872013000300014. Review. Spanish.

13.

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.

JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.

PMID:
23712469
14.

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.

Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P, Pupi A, de Leon MJ, Mosconi L.

J Nutr Health Aging. 2015 Apr;19(4):413-23. doi: 10.1007/s12603-014-0534-0.

15.

Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain.

Bero AW, Bauer AQ, Stewart FR, White BR, Cirrito JR, Raichle ME, Culver JP, Holtzman DM.

J Neurosci. 2012 Mar 28;32(13):4334-40. doi: 10.1523/JNEUROSCI.5845-11.2012.

16.

Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.

Yi D, Lee DY, Sohn BK, Choe YM, Seo EH, Byun MS, Woo JI.

Am J Geriatr Psychiatry. 2014 Oct;22(10):961-70. doi: 10.1016/j.jagp.2013.12.173.

PMID:
24495404
17.

Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease.

Brinton RD.

Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1504-11. doi: 10.1016/j.addr.2008.06.003. Review.

18.

Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.

Seo JS, Yun JH, Baek IS, Leem YH, Kang HW, Cho HK, Lyu YS, Son HJ, Han PL.

J Ethnopharmacol. 2010 Mar 2;128(1):206-12. doi: 10.1016/j.jep.2010.01.014.

PMID:
20079417
19.

Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.

Bigl M, Apelt J, Eschrich K, Schliebs R.

J Neural Transm (Vienna). 2003 Jan;110(1):77-94.

PMID:
12541014
20.

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.

Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC.

JAMA Neurol. 2013 May;70(5):600-6. doi: 10.1001/jamaneurol.2013.1342.

Items per page

Supplemental Content

Support Center